Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

ShouTi follows October debut by hiring Credit Suisse’s Ding as CFO

Plus: C4X, IMV and Neuvogen

December 22, 2021 11:25 PM UTC

ShouTi Inc. hired former Credit Suisse banker Ding Ding as CFO. Ding was Credit Suisse’s head of APAC healthcare investment banking and capital markets. ShouTi, which has offices in Shanghai and South San Francisco, emerged from stealth in October with a crossover $100 million series B round and a platform to develop oral small molecules to replace GPCR-targeting biologics and peptides for chronic cardiovascular, metabolic and pulmonary diseases. The company’s lead program is in Phase I testing for pulmonary arterial hypertension. Investors in the series B included BVF, Casdin Capital, Cormorant Asset Management, Janus Henderson Investors, Lilly Asia Ventures.

Drug discovery company C4X Discovery Holdings plc (LSE:C4XD) hired Catherine Tralau-Stewart as CSO, effective Jan. 4. Tralau-Stewart joins C4X from Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK), where she was a senior director of alliances. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article